Exciting News! Our new name is now officially The Mast Cell Disease Society, Inc. (TMS). Over the coming weeks, we will still be transitioning our name across all of our platforms. We are so thrilled to now have a name that is inclusive of everyone in our community!
Patients, Caregivers & Advocates: Save the date for FDA’s Rare Disease Day public meeting on February 24, 2020! Learn about how FDA supports medical product development for rare diseases. More info coming soon! #FDArare2020@RareDiseases@ncats_nih_gov https://t.co/s1JCV8Zmzo
This #NationalCaregiversMonth, we applaud the countless individuals who empower loved ones facing health challenges. For resources on supporting others, visit @CaregiverAction: https://t.co/7iuHXr8HKz
Today is the second annual Mastocytosis Awareness Day. #Mastocytosis is a rare disorder affecting less than 250,000 people in the US. (Pop. 34 million) While every person has them; Mastocytosis is characterized by an over abundance of #MastCells@tmsforacure@MastocytosisCA
But thanks to several companies, the tides are slowly beginning to turn. Business leaders are recognizing just how capable the disabled community is, and they are actively striving to add these individuals to their workforce. https://t.co/x4xhiiG1nB
@BlueprintMeds@BrighamWomens An amazing day with the most compassionate corporate culture I have ever experienced. Thank you for sharing your time with us.